Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

VIDO-InterVac running vaccine trial in Africa as Omicron variant spreads

VIDO-InterVac director and CEO Dr. Volker Gerdts tells Global News Morning they are trialling their Saskatoon-made COVID-19 vaccine in Africa — and gives his thoughts on the Omicron variant.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article